Page last updated: 2024-08-26

cilastatin and Bacteremia

cilastatin has been researched along with Bacteremia in 21 studies

Research

Studies (21)

TimeframeStudies, this research(%)All Research%
pre-19901 (4.76)18.7374
1990's7 (33.33)18.2507
2000's8 (38.10)29.6817
2010's4 (19.05)24.3611
2020's1 (4.76)2.80

Authors

AuthorsStudies
Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W1
Chen, CH; Lin, CH; Lin, JS1
Advincula, MR; McLaughlin, MM; Miglis, C; Scheetz, MH; Skoglund, E; Wagner, J1
Bai, KJ; Hsieh, TC; Hsu, CW; Jean, SS; Lam, C; Lee, WS1
Isome, K; Iwata, A; Matsubara, K; Nigami, H; Tasaka, K; Yamamoto, G1
Batlle, M; de la Cámara, R; de la Rubia, J; Debén, G; Díaz, J; García, R; Jarque, I; Juliá, A; Lahuerta, JJ; López, J; Martino, R; Montesinos, P; Rovira, M; Sanz, MA; Vázquez, L1
Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K1
Anagnostopoulos, A; Fassas, A; Hadjikyrkou, M; Kontodimou, A; Papageorgiou, T; Proya, E1
Choi, JY; Kim, CO; Kim, JM; Kim, MS; Kim, YA; Kim, YK; Lee, K; Park, YS; Shin, SY; Song, YG; Yong, D; Yoon, HJ1
Archontoulis, N; Giamarellos-Bourboulis, EJ; Giamarellou, H; Mega, A; Pavleas, I; Rigas, K; Thomopoulos, G; Vernikos, P1
Bonnaure-Mallet, M; Jolivet-Gougeon, A; Sixou, JL; Tamanai-Shacoori, Z1
Chang, CM; Chuang, YC; Ko, WC; Lee, HC; Lee, NY; Wang, CL; Wang, LR; Yu, WL1
Bleichrodt, RP; Kooi, K; Rosman, C; van Oeveren, W; Westerveld, GJ1
Fujita, Y; Fukabori, T; Mizobuchi, K; Nakamura, M; Takashina, R; Takizawa, H1
Garnache, F; Goffinet, P; Simon, M1
Lopez, SM; Rowen, JL1
Başkan, S; Ozyilkan, O; Yalçintaş, U1
Geddes, A; Härkönen, M; Jacobs, F; Nowotny, I; Schonwald, S; Thaler, M1
Böswald, M; Döbig, C; Guggenbichler, JP; Kändler, C; Krüger, C; Scharf, J; Soergel, F; Zink, S1
Jellison, TK; Mckinnon, PS; Rybak, MJ1
Cid, A; Jarque, I; Martín, G; Pérez-Bellés, C; Salavert, M; Sanz, MA1

Reviews

1 review(s) available for cilastatin and Bacteremia

ArticleYear
Antimicrobial treatment of Capnocytophaga infections.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Capnocytophaga; Cilastatin; Clindamycin; Endocarditis, Bacterial; Gram-Negative Bacterial Infections; Humans; Imipenem; Immunocompromised Host; Microbial Sensitivity Tests

2007

Trials

4 trial(s) available for cilastatin and Bacteremia

ArticleYear
Impact of carbapenem administration on systemic endotoxemia in patients with severe sepsis and Gram-negative bacteremia.
    Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:5

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; C-Reactive Protein; Carbapenems; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Endotoxemia; Female; Gram-Negative Bacterial Infections; Humans; Imipenem; Interleukin-6; Lipopolysaccharides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Sepsis

2006
[Effect of imipenem/cilastatin combined with vancomycin for MRSA infection].
    The Japanese journal of antibiotics, 1997, Volume: 50, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Methicillin Resistance; Middle Aged; Pneumonia, Staphylococcal; Staphylococcal Infections; Urinary Tract Infections; Vancomycin

1997
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients.
    The Korean journal of internal medicine, 1999, Volume: 14, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam

1999
Levofloxacin in the empirical treatment of patients with suspected bacteraemia/sepsis: comparison with imipenem/cilastatin in an open, randomized trial.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Therapy, Combination; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Levofloxacin; Middle Aged; Ofloxacin; Protease Inhibitors; Sepsis; Thienamycins

1999

Other Studies

16 other study(ies) available for cilastatin and Bacteremia

ArticleYear
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines

2021
Bacteremia caused by Elizabethkingia meningoseptica in a mechanically ventilated patient successfully treated with imipenem-cilastatin and ciprofloxacin.
    Revista do Instituto de Medicina Tropical de Sao Paulo, 2017, 06-01, Volume: 59

    Topics: Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Multiple, Bacterial; Flavobacteriaceae Infections; Humans; Imipenem; Male; Middle Aged

2017
Effect of elevated imipenem/cilastatin minimum inhibitory concentrations on patient outcomes in Gram-negative bloodstream infections.
    Journal of global antimicrobial resistance, 2018, Volume: 13

    Topics: Aged; Bacteremia; Cilastatin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Treatment Outcome

2018
Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of cl
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:6

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Imipenem; Male; Microbial Sensitivity Tests; Middle Aged; Minocycline; Pneumonia, Ventilator-Associated; Salvage Therapy; Sulbactam; Taiwan; Tigecycline; Treatment Outcome

2016
[Invasive Campylobacter jejuni/coli Infections: 9 Case Reports at a Single Center between 2000 and 2015, and a Review of Literature Describing Japanese Patients].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 2016, Volume: 90, Issue:3

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Campylobacter Infections; Campylobacter jejuni; Child; Child, Preschool; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Female; Humans; Imipenem; Japan; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult

2016
Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:4

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Disease-Free Survival; Female; Glycopeptides; Hematologic Neoplasms; Humans; Imipenem; Male; Middle Aged; Neutropenia; Protease Inhibitors; Retrospective Studies; Spain; Stem Cell Transplantation; Survival Rate; Teicoplanin; Transplantation, Autologous; Vancomycin

2009
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:5

    Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins

2004
Imipenem/cilastatin as initial single-agent therapy for infections in cancer patients with neutropenia.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Neutropenia; Treatment Outcome

1989
Comparison of efficacy of cefoperazone/sulbactam and imipenem/cilastatin for treatment of Acinetobacter bacteremia.
    Yonsei medical journal, 2006, Feb-28, Volume: 47, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cefoperazone; Cilastatin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Protease Inhibitors; Sulbactam

2006
Combination carbapenem-sulbactam therapy for critically ill patients with multidrug-resistant Acinetobacter baumannii bacteremia: four case reports and an in vitro combination synergy study.
    Pharmacotherapy, 2007, Volume: 27, Issue:11

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Illness; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Sulbactam; Taiwan; Thienamycins

2007
Effect of intraperitoneal antimicrobials on the concentration of bacteria, endotoxin, and tumor necrosis factor in abdominal fluid and plasma in rats.
    European surgical research. Europaische chirurgische Forschung. Recherches chirurgicales europeennes, 1996, Volume: 28, Issue:5

    Topics: Abdomen; Animals; Anti-Bacterial Agents; Bacteremia; Bacteria; Body Fluids; Cilastatin; Colony Count, Microbial; Endotoxins; Imipenem; Injections, Intraperitoneal; Male; Osmolar Concentration; Rats; Rats, Wistar; Survival Analysis; Taurine; Thiadiazines; Tumor Necrosis Factor-alpha

1996
[Primary peritonitis caused by Streptococcus pneumoniae].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1997, Volume: 26, Issue:6

    Topics: Abdominal Pain; Adult; Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Cilastatin; Diarrhea; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Laparotomy; Penicillins; Peritonitis; Pneumococcal Infections; Protease Inhibitors; Puerperal Infection; Thienamycins; Treatment Outcome; Vagina

1997
Morganella morganii early onset sepsis.
    The Pediatric infectious disease journal, 1998, Volume: 17, Issue:12

    Topics: Adult; Ampicillin Resistance; Bacteremia; Cefotaxime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Follow-Up Studies; Gentamicins; Humans; Imipenem; Infant, Newborn; Injections, Intravenous; Male; Pregnancy; Pregnancy Complications, Infectious; Proteus; Proteus Infections; Puerperal Infection; Treatment Outcome

1998
Pharmacokinetic and clinical evaluation of serious infections in premature and newborn infants under therapy with imipenem/cilastatin.
    Infection, 1999, Volume: 27, Issue:4-5

    Topics: Bacteremia; Cilastatin; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Infusions, Intravenous; Intensive Care Units, Neonatal; Male; Prognosis; Protease Inhibitors; Retrospective Studies; Severity of Illness Index; Survival Rate; Thienamycins

1999
Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam.
    Pharmacotherapy, 2001, Volume: 21, Issue:2

    Topics: Acinetobacter Infections; Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin; Bacteremia; Chi-Square Distribution; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Sulbactam; Treatment Outcome

2001
Recurrent bacteremia caused by Rhodococcus equi in a non-neutropenic patient with acute myeloid leukemia in complete remission.
    Haematologica, 2002, Volume: 87, Issue:1

    Topics: Actinomycetales Infections; Adult; Amikacin; Bacteremia; Catheters, Indwelling; Ceftazidime; Cilastatin; Drug Resistance; Drug Therapy, Combination; Erythromycin; Female; Humans; Imipenem; Immunocompromised Host; Leukemia, Myelomonocytic, Acute; Neutropenia; Pneumonia, Bacterial; Recurrence; Rhodococcus equi; Vancomycin

2002